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Mitogen- and Stress-Activated Protein Kinase 2
and Cyclic AMP Response Element Binding Protein
are Activated in Lesional Psoriatic Epidermis
Anne T. Funding1, Claus Johansen1, Knud Kragballe1 and Lars Iversen1
The activity of the p38 mitogen-activated protein kinases (MAPKs) is increased in lesional psoriatic skin,
supporting a possible role of these kinases in the pathogenesis of psoriasis. Recently, increased focal activation
of the downstream target mitogen- and stress-activated protein kinase 1 (MSK1) was demonstrated in psoriatic
epidermis. The purpose of this study is to investigate MSK2 and the transcription factor cyclic adenosine
monophosphate response element-binding protein (CREB) in psoriatic skin and in cultured normal human
keratinocytes. In lesional psoriatic skin, significantly increased MSK2 (Ser196) and CREB (Ser133) activation was
demonstrated by phospho blotting. Immunofluorescence staining of phosphorylated MSK2 (Ser196) revealed
colocalization with phosphorylated MSK1 (Thr 581) in the epidermis. Keratinocyte cultures stimulated with
anisomycin and IL-1b showed increased MSK2 (Ser196) and CREB (Ser133) phosphorylation. Such activation was
abolished during preincubation with a p38 inhibitor. Keratinocytes transfected with small interfering RNA
showed a stronger decrease in CREB phosphorylation in MSK1/2 double-transfected cells than in MSK1 and
MSK2 single-transfected cells. This study demonstrate for the first time the expression of MSK2 in keratinocytes
and increased MSK2 and CREB activation in lesional psoriatic skin. Our results indicate that the p38-MAPK/
MSK1/MSK2 and CREB signalling pathway may play a role in the pathogenesis of psoriasis.
Journal of Investigative Dermatology (2007) 127, 2012–2019; doi:10.1038/sj.jid.5700821; published online 12 April 2007
INTRODUCTION
Cells respond to various extracellular stimuli by transmitting
the signals to the inside of the cell. Specific signal
transduction pathways build up inside the cell to integrate a
stimuli-specific response. This allows control of a number
of cellular processes including cell cycle, proliferation,
differentiation, and apoptosis. The mitogen-activated
protein kinase (MAPK) signal transduction pathways are
among the best characterized intracellular signalling
cascades (Robinson and Cobb 1997). Four classical MAPKs
have been described (Roux and Blenis, 2004). These are
the extra cellular signal-regulated kinases 1 and 2 (ERK1/2),
the p38, and the c-jun amino-terminal kinases. Also,
atypical MAPKs like ERK3 and ERK5 have been identified
(Ashwell, 2006).
Psoriasis is a chronic, hyperproliferative, inflammatory
disorder characterized by abnormal growth of epidermal
keratinocytes driven by activated T lymphocytes (McKenzie
and Sabin, 2003; Bos et al., 2005). The keratinocyte
hyperproliferation as well as the inflammatory response
may be stimulated by an imbalance in various signal
transduction pathways, including increased p38 MAPK
signalling pathway activity as previously shown by our group
(Johansen et al., 2004, 2005b).
Mitogen- and stress-activated protein kinase 2 (MSK2) is a
downstream target of both the p38 and the ERK1/2 MAPKs
(Pierrat et al., 1998). MSK2 was identified in 1998 together
with MSK1 (Deak et al., 1998; New et al., 1999). Human
MSK1 and MSK2 share 75% homology in their primary
structure. They are both capable of phosphorylating multiple
transcription factors and nuclear proteins (Vermeulen et al.,
2002, 2003; Soloaga et al., 2003), and a number of studies
have supported a role of MSK1 and MSK2 in phosphorylation
of the nuclear transcription factor cyclic adenosine mono-
phosphate response element-binding protein (CREB) (Deak
et al., 1998; Pierrat et al., 1998).
In a very recent publication, we demonstrated increased
phosphorylation of MSK1 (Ser376) in lesional compared with
nonlesional psoriatic skin (Funding et al., 2006). MSK1 was
found to be involved in the phosphorylation of CREB in
keratinocytes and in the regulation of the expression of the
proinflammatory cytokines IL-6, IL-8, and tumor necrosis
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factor-a (Funding et al., 2006). The p38 MAPK/MSK1
signalling pathway may, therefore, play a potential role in
the pathogenesis of psoriasis, as suggested by Arthur and
Darragh (2006).
Studies of MSK1 and MSK2 single knockout mice
showed partial suppression in anisomycin-induced
phosphorylation of CREB and activation transcription factor
1 (ATF1), whereas phosphorylation was nearly abolished
in MSK1/2 double-knockout cells (Wiggin et al., 2002).
This indicates that MSK2 contributes to CREB and ATF1
phosphorylation and that MSK1 and MSK2 have over-
lapping functions. It was therefore, of paticular interest to
determine the activity and to characterize the role of
both MSK2 and CREB in psoriatic skin and in human
keratinocytes.
This study is the first to demonstrate that MSK2 is
significantly phosphorylated (activated) in lesional psoriatic
epidermis and that it colocalizes with phosphorylated MSK1.
This study also demonstrates that the two MSK1 and MSK2
substrates CREB and ATF1, are strongly activated in lesional
psoriatic epidermis. Furthermore, we demonstrate a role of MSK2
in CREB phosphorylation in cultured normal human keratino-
cytes. Taken together, our data indicate that MSK2 and MSK1
may serve as potential targets in the treatment of psoriasis.
RESULTS
Increased MSK2 and CREB activation in lesional psoriatic skin
compared with nonlesional psoriatic skin
Whole-cell extracts from lesional and nonlesional psoriatic
skin were isolated and the phosphorylated forms of MSK2
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Figure 1. MSK2 and CREB activation in lesional psoriatic skin. From lesional and nonlesional psoriatic skin paired keratome biopsies were obtained and
homogenized. (a) Whole-cell protein extracts were isolated and equal amounts of protein were separated by gel electrophoresis on a gradient gel. After the
electroblotting, the separated proteins were probed with anti-phospho-MSK2 (Ser196), anti-phospho-MSK1 (Thr581), anti-phospho-CREB, anti-CREB,
or anti-MSK2 antibodies. Densitometic analysis of the band intensity was carried out and values were normalized to b-actin. (b) Phospho-MSK2 (Ser196),
phospho-MSK1 (Thr581), phospho-CREB, phospho-ATF1, CREB, and MSK2 in lesional psoriatic skin compared with nonlesional skin. The intensity is presented
as mean7SD (arbitrary units). All: n¼ 3, except phospho-MSK1: n¼4; *Po0.05.
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(Ser196), MSK1 (Thr581), CREB, and ATF1 as well as total
protein expression of CREB, MSK2, and b-actin were
determined by Western blotting in psoriatic skin (Figure 1a).
Band intensity analysis was also carried out and values were
normalized to b-actin. We found a significant increase in the
phosphorylated form of MSK2 (Ser196), MSK1 (Thr581),
CREB, and ATF1 in the lesional psoriatic skin compared
with nonlesional psoriatic skin (Figure 1b). No significant
alterations were seen in the total level of CREB and MSK2
when band intensity was normalized to b-actin expression
(Figure 1b).
Immunofluorescence analysis demonstrate colocalization
between activated MSK2 and MSK1
To examine the phospho-MSK2 localization in lesional and
nonlesional psoriatic skin, immunofluorescence imaging of
the Ser196 phosphorylated form of MSK2 were made in
biopsies from six psoriatic patients. The phosphorylated
MSK2 was detected exclusively in single keratinocytes in
the basal layers of the epidermis (Figure 2a). The localization
was primarily in the nuclei, but some phospho-MSK2 was
also found in the cytosol of the keratinocytes. These strongly
phospho-MSK2-positive cells were not detected in non-
lesional psoriatic skin. Phosphorylated MSK1 (Thr581) has
previously been demonstrated to have a similar distribution
pattern in lesional psoriatic skin (Funding et al., 2006). To
examine whether phosphorylated MSK2 (Ser196) colocalized
with phosphorylated MSK1 (Thr 581), double stainings
of phosphorylayed MSK2 and zenon-labelled phosphory-
lated MSK1 were done. The phosphorylated MSK2 colo-
calized with phosphorylated MSK1 in lesional psoriatic skin
(Figure 2b).
The localization of total MSK2 is seen in Figure 2c. Total
MSK2 stained in the keratinocytes throughout the epidermis,
the staining was found in the nuclei and cytosol.
MSK2 (Ser196) is activated through the p38 MAPK in
cultured normal human keratinocytes
To determine the MSK2 (Ser196) activation in cultured
normal epidermal keratinocytes, they were incubated with
either IL-1b or the p38 MAPK-activator anisomycin for
various time points (Figure 3a). The activation of MSK2
(Ser196), MSK1 (Thr581), CREB (Ser133), and ATF1 were
determined by phospho-blotting of whole-cell extracts
(Figure 3a). The MSK2, MSK1, and CREB phosphorylation
reached a maximum 15–30 minutes after stimulation with
both anisomycin and IL-1b (Figure 3a). An anti-p38 antibody
was used as loading control (Figure 3a).
The keratinocytes were also preincubated with the p38-
inhibitor SB 202190, 30 minutes before stimulation with
anisomycin or IL-1b, to study the signalling pathway of
anisomycin and IL-1b-induced MSK2 (Ser196), MSK1
(Thr581), CREB, and ATF1 activations. Preincubation with
the SB 202190 strongly inhibited anisomycin and IL-1b-
induced MSK2 (Ser196), MSK1 (Thr581), CREB (133), and
ATF1 phosphorylation in the human keratinocytes (Figure
3b). Equivalent loading was confirmed by evaluating total
p38 expression (Figure 3b).
CREB phosphorylation is regulated through MSK2 as well as
MSK1 in cultured human keratinocytes
The involvement of MSK2 as well as MSK1 in CREB
phosphorylation was investigated in cultured human kerati-
nocytes transfected with MSK1 small interfering RNA
(siRNA), MSK2 siRNA, or MSK1/MSK2 siRNA. Keratinocytes
transfected with siControl (10 or 20 nM) were used as controls
in the same experiment. MSK1, MSK2, and phospho-CREB
levels were determined by Western blotting of whole-cell
extract and band intensity analysis was carried out. The
anisomycin-induced CREB activation decreased significantly
in the single MSK1 and MSK2 siRNA-transfected cells by 63
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Figure 2. Colocalization between activated MSK1 and MSK2 in lesional psoriatic skin. (a) Immunofluorescence staining of phospho-MSK2 (Ser196) and
(c) total MSK2 in paired punch biopsies from psoriatic patients (lesional and nonlesional psoriatic epidermis). (b) Double staining of phospho-MSK1 (Thr581)
and phospho-MSK2 (Ser196) in lesional psoriatic epidermis. The blue color (40, 6-diamidine-20-phenylindole dihydrochloride) stains the cells nuclei. The green
color stains the (b) phosphorylated MSK1 and the red color stains the (a and b) phosphorylated MSK2 or (c) total MSK2. Yellow color indicates colocalization.
The white bar represents (a and c) 100 mm and (b) 25 mm. The fluorescence images shown here are representative of the six psoriatic patients investigated.
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and 37%, respectively (Po0.05), compared with the 10 nM
siControl-transfeceted cells (Figure 4). However, this
decrease in CREB activation was even higher 92%, (Po0.05),
in the double MSK1/MSK2 siRNA-transfected cells compared
with the 20 nM siControl (Figure 4). The mean total MSK1 and
MSK2 protein contents in the keratinocytes were reduced 96
and 95% in the transfected cells (Figure 4). Equal loading was
confirmed by incubation with an anti-p38 antibody.
Localization by immunofluorescence analysis of phosphorylated
CREB in lesional psoriatic skin
To investigate the localization of Ser133-phosphorylated
CREB in psoriatic skin, immunofluorescence imaging of
paired punch biopsies was made. A comparison staining of
lesional psoriatic skin and nonlesional psoriatic skin was
made. In all six patients investigated, a strong staining of
Ser133-phosphorylated CREB was seen in keratinocytes
throughout the lesional psoriatic epidermis (Figure 5). The
Ser133 phospho-CREB-positive cells stained positive to
keratin 14, a specific marker for keratinocytes. The nuclei
were localized with 40,6-diamidine-20-phenylindole di-
hydrochloride. The staining of phosphorylated CREB accumu-
lated in the nuclei (Figure 5). No staining of phosphorylated
CREB was found in the nonlesional psoriatic skin.
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Figure 3. Activation of MSK2 and CREB by anisomycin and IL-1b in cultured
normal human keratinocytes. Cultured normal human keratinocytes were
stimulated with (a) anisomycin (0.2 mg/ml) or IL-1b (10 ng/ml) for 5, 15, 30,
60, or 240 minutes (b) or preincubated with SB 202190 30 minutes before
incubation with anisomycin (0.2 mg/ml) or IL-1b (10 ng/ml) for 15 minutes.
Whole-cell extracts were isolated and separated by SDS-PAGE on a gradient
gel. The gels were blotted onto a membrane and probed with
anti-phospho-MSK1 (Thr581), anti-phospho-MSK2 (Ser196), or anti-phospho-CREB
(Ser133) antibody. Equal loading was controlled by incubating with an
anti-p38 antibody. Representative gels of at least three different experiments
are shown.
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Figure 4. Effects of single and double MSK1 and MSK2 siRNA transfection on
CREB phosphorylation. Cultured human keratinocytes were transfected with
nonspecific siControl (10 or 20 nM), MSK1 (10 nM), MSK2 (10 nM), or MSK1
and MSK2 (final siRNA concentration of 20 nM) for 5 hours. The cells were
grown for additional 48 hours before stimulation for 15 minutes with
anisomycin (0.2 mg/ml). Whole-cell extracts were isolated and separated by
SDS-PAGE on a gradient gel. The membranes were probed with
anti-phospho-CREB, anti-MSK1, or anti-MSK2. Equal loading was controlled
by incubating with an anti-p38 antibody. Representative gels of at least three
different experiments are shown.
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Figure 5. Localization of activated CREB in lesional and nonlesional
psoriatic skin. Immunofluorescence staining of phosphorylated CREB (Ser133)
in paired punch biopsies from psoriatic patients (lesional and nonlesional
psoriatic epidermis). The blue color (40, 6-diamidine-20-phenylindole
dihydrochloride) stains cell nuclei. The green color stains the keratin 14 and
the red color stains the phosphorylated CREB (Ser133). The white bar
represents 25 mm. The figure show representative fluorescence images of six
psoriatic patients investigated.
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The antibody used to detect phosphorylated MSK2 (Ser196)
does not cross-react with MSK1
To preclude any chance of MSK1 binding to the anti-pospho-
MSK2 (ser196) antibody used in this study, immunoprecipita-
tions were made. Cultured normal human keratinocytes were
incubated with anisomycin for 15 and 30 minutes (Figure 6).
A total amount of 500mg protein was pooled and immuno-
precipitated with either anti-MSK1 or -MSK2 before Western
blot analysis with anti-phosphorylated MSK2 was made. We
found a strong activation of phosphorylated MSK2 at 15 and
30 minutes in the cell extract immunoprecipitated with MSK2
(Figure 6a). No phosphorylated MSK2 were seen in the cell
extract immunoprecipitated with anti-MSK1 (Figure 6b). The
level of phosphorylated p38 MAPK was also investigated and
as expected a strong activation was seen (Figure 6c). Total
MSK2 was not seen in MSK1-immunoprecipitated cell lysate.
Total MSK1 was not detected in MSK2-immunoprecipitated
cell lysate (data not shown).
DISCUSSION
This study reveals three essential and novel findings which all
provide new information regarding the p38 MAPK/MSK1/
MSK2/CREB signalling pathway in psoriasis and human
keratinocytes. First, a significant increased MSK2 (Ser196)
activation was demonstrated in lesional psoriatic skin
compared with nonlesional psoriatic skin, whereas no
alterations were seen in total MSK2 expression. Secondly,
activated MSK2 was shown to be localized focally in the
epidermis of lesional psoriatic skin and colocalized with
activated MSK1. Finally, the transcription factor CREB was
significantly activated in lesional psoriatic skin and localized
throughout the epidermis (the activated form).
Previously, MSK1 has been suggested to play a significant
role in the pathogenesis of psoriasis (Arthur and Darragh,
2006; Funding et al., 2006). MSK1 is activated by p38 MAPK
or ERK1/2 through activation of either Ser376 or Thr581
(Chrestensen and Sturgill, 2002; Mccoy et al., 2005). MSK2 is
a protein kinase closely related to MSK1, although less well
characterized. It is activated through a phosphorylation of
Ser196 (Roux and Blenis, 2004). Studies of double MSK1 and
MSK2 knockout mice have suggested that MSK1 and MSK2
are able to compensate functionally for each other (Wiggin
et al., 2002). It is therefore of particular interest that this study
demonstrates dramatically increased MSK2 activation, with-
out alternations in total MSK2 protein expression level, in
lesional psoriatic skin compared with nonlesional psoriatic
skin. These data are in accordance with the highly increased
Ser376 MSK1 activation found in lesional psoriatic skin
(Funding et al., 2006) and the increased Thr581 MSK1
activation in lesional psoriatic skin found in this study. The
increased activations of both MSK1 and MSK2 indicate a role
of both kinases in the pathogenesis of psoriasis and to our
knowledge this is the first time MSK2 is investigated in the
skin and in psoriasis.
Recently, MSK1 was demonstrated to be localized
selectively in keratinocytes focally in the lesional psoriatic
epidermis (Funding et al., 2006). Interestingly, colocalization
fluorescence imaging demonstrated that the activated MSK2
were actually localized in the same keratinocytes as activated
MSK1 (Figure 2b). Although MSK1 and MSK2 have been
suggested to have overlapping effects (Wiggin et al., 2002),
activated MSK1 and MSK2 have never previously been
demonstrated to colocalize. The immunofluorescence stain-
ing of psoriatic epidermis is a snapshot of a moving picture;
we therefore believe that the few phospho MSK1- and MSK2-
positive cells seen in Figure 2a are results of a snapshot of
kinase activation. This is confirmed by the in vitro studies;
here, the activation of MSK1 and MSK2 decreases markedly
after 30 minutes of stimulation with the physiological stimuli
IL-1b. In addition, the strong activation in the specific
keratinocytes may put in shade some weaker activation in
some of the other keratinocytes.
On the discovery of MSK1 and MSK2, they were shown to
be the major activation factors for CREB when stimulated
with agonists that activate p38 MAPK (Deak et al., 1998;
Pierrat et al., 1998). To elucidate further the overlapping
functions between these two kinases, we studied the role of
MSK1 and MSK2 in the regulation of stress-induced CREB
activation in vitro. We demonstrated that in human kerati-
nocytes, MSK2 as well as MSK1 contributed to CREB
activation and that an even stronger inhibitory effect
on stress-induced CREB activation was seen in double
MSK1/MSK2 siRNA-transfected cells than in single MSK1
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Figure 6. Control studies of phosphorylated MSK2 antibody. Cultured
human keratinocytes were incubated with anisomycin for 15 and 30 minutes.
Cell extract from several dishes were pooled. Whole-cell extract (500 mg)
were immunoprecipitated with either (a) MSK2 or (b) MSK1. The
immunoprecipitates were isolated and separated onto a gradient gel.
(a and b) After electroblotting, the separated proteins were probed with
anti-phospho-MSK2. (c) A Western blotting using anti-phospho-p38 was
conducted. Equal loading was confirmed by incubating with an (a) anti-MSK2,
(b) anti-MSK1, or (c) anti-p38 antibody. Representative gels of at least three
different gels are shown.
2016 Journal of Investigative Dermatology (2007), Volume 127
AT Funding et al.
MSK2 and CREB Activity in Psoriatic Skin
and MSK2 siRNA-transfected cells. Studies of knockout mice
fibroblasts demonstrated a similar participation of MSK2 in
the regulation of CREB activation (Wiggin et al., 2002). In the
same knockout cells, the activation of MSK1, MSK2, and
CREB were all maximal at the same time after stress exposure.
In human keratinocytes, as presented here, a comparable
activation pattern was seen during anisomycin and IL-1b
incubation, with a simultanious peak in activations of the
three kinases. Our results underscore the importance of
studying MSK2 as well as MSK1 in human keratinocytes.
MSK1 and MSK2 phosphorylates transcription factors like
CREB and ATF1 but also the p65 subunit of NF-kB has been
demonstrated to be activated by MSK1 (Kefaloyianni et al.,
2006; Vermeulen et al., 2002, 2003). Recently, the c-fos gene
expression was demonstrated to be MSK1 regulated in the
human keratinocyte cell line, HaCaT (Schiller et al., 2006).
Thereby, MSK1 and MSK2 regulate the expression of different
proinflammatory genes. NF-kB has been shown to be
activated in several inflammatory conditions including
psoriasis (Tak and Firestein, 2001; Lizzul et al., 2005;
Johansen et al., 2005a). In contrast, CREB activation has
never been determined in psoriasis before. In the light of the
activation of MSK1 as well as MSK2 in lesional psoriatic skin,
we determined CREB phosphorylation in psoriatic skin. The
phospho-immunoblotting performed here demonstrated a
significant activation of CREB in lesional psoriatic skin.
Interestingly, phosphorylated CREB demonstrated staining in
keratinocytes throughout the lesional psoriatic epidermis and
not in single positive cells like the phospho-MSK1 and -MSK2
(Figure 5). Distinguishing characteristics between MSK1/
MSK2 and CREB have earlier been described. Mice lacking
MSK1/MSK2 are viable and fertile and had no obvious health
problems, whereas CREB knockouts have severe phenotypes
(Bourtchuladze et al., 1994). As previously suggested (Wiggin
et al., 2002), this difference can reflect a wider role of CREB
in mediating the effects of many agonists that act via different
signal transduction cascades.
In summary, the activity of the p38 MAPKs is increased in
lesional psoriatic skin, supporting a potential role of these
kinases in the pathogenesis of psoriasis. Recently, increased
focal activation of the downstream target MSK1 was
demonstrated in psoriatic epidermis. This study demonstrates
for the first time the expression of MSK2 in keratinocytes and
increased MSK2 and CREB activation in lesional psoriatic
skin. Our results indicate that the p38-MAPK/MSK1/
MSK2 and CREB signalling pathway may play a role in the
pathogenesis of psoriasis.
MATERIALS AND METHODS
Biopsies
Keratome biopsies and punch biopsies were obtained as described
previously (Johansen et al., 2005b; Funding et al., 2006) from
lesional psoriatic skin and from nonlesional psoriatic skin,
using ZimmerTM Electronic Dermatome (Zimmer Orthopaedic,
Dover, OH). The dermatome was adjusted according to the degree
of infiltration, as evaluated clinically. When nonlesional biopsies
were obtained, the depth of cut was reduced. The keratome
biopsies were immediately snap-frozen in liquid nitrogen. The
punch biopsies were paraffin-embedded and 4-mm sections were
placed on slides.
The study was conducted according to the Declaration of
Helsinki Principles. The medical ethical committee of Aarhus
approved the study. Informed consent was obtained from each
patient.
Cell cultures
From patients undergoing plastic surgery, normal adult human
keratinocytes were obtained by trypsinisation of skin samples as
described previously (Kragballe et al., 1985). Second-passage
keratinocytes were grown in keratinocyte serum-free medium
(Invitrogen, Carlsbad, CA). The medium was changed to keratino-
cyte basal medium (the same as keratinocyte serum-free medium but
without growth factors) 24 hours before stimulation. The cells were
stimulated with anisomycin (0.2 mg/ml; Sigma Aldrich, St Louis, MO)
or IL-1b (10 hours/ml; R&D Systems, Oxon, UK). In some experi-
ments, the keratinocytes were pretreated with the p38a/b-inhibitor
SB 202190 (10 mM; Calbiochem, San Diego, CA) 30 minutes before
stimulation. Cells were grown at 371C and 5% CO2.
Isolation of protein from cells
A solution containing 50 mM Tris–HCl, pH 6.8, 10 mM dithiothreitol,
10 mM b-glycerophosphate, 10 mM sodium flouride, 0.1 mM sodium
orthovanadate, 10% glycerol, 2.5% SDS (Sigma Aldrich, St Louis,
MO), phenylmethylsulfonyl fluoride, and a complete proteinase-
inhibitor cocktail were used to the lysation of the cells. The lysates
were boiled for 3 minutes, incubated with benzon nuclease for
15 minutes, and then centrifuged at 13.600 g for 3 minutes at 41C
and the supernatants were removed and stored at 801C until use.
Isolation of protein from keratome biopsies and cells for
immunoprecipitation
The biopsies and cells for immunoprecipitation were homogenized
in a cell lysis buffer (20 nM Tris—base, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1% Triton-X-100, 2.5 mM sodium pyrophos-
phate, 1 mM b-glycerolphosphate, 1 mM Na3VO4, 1mg/ml leupeptin,
and 1 mM phenylmethylsulfonyl fluoride). Homogenization of the
biopsies was carried out by using a TissueLyser from Qiagen (Haan,
Germany). The homogenization was carried out for 2 2 minutes.
The samples were left on ice for 10 minutes. The samples were
sonicated 5 10 seconds and again left on ice for 10 minutes, before
they were centrifuged at 10,000 g for 10 minutes at 41C. The
supernatant constituted the cell lysate.
Western blot analysis
Equal amount of whole-cell protein extracts (determined by
Bradford) were separated by SDS-PAGE and blotted onto nitrocellu-
lose membranes. Membranes were incubated with either anti-
phospho-p38, -phospho-MSK1(Thr581), -phospho-CREB(Ser133),
-p38, -CREB (Cell Signalling Technology, Beverly, MA), phospho-
MSK2 (Ser196), -MSK1(Santa Cruz, Biotechnology, Santa Cruz, CA),
or -MSK2 (R&D Systems) and detected with horseradish peroxidase-
conjugated anti-rabbit (Cell Signalling Technology), anti-rat or -goat
(DAKO, Glostrup, Denmark) in a standard ECL reaction (Cell
Signalling Technology). A biotinylated protein ladder molecular
weight marker (Cell Signalling Technology) was used for estimation
of protein size. In control studies, we found that the phospho-MSK2
www.jidonline.org 2017
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(90 KDa) band was similar to the phospho-MSK2 band seen in Figure
6a, where whole-cell extract was immunoprecipitated with total
MSK2 before Western blot analysis.
Immunoprecipitation – MSK2
Protein G Sepharose 4 Fast Flow (GE Healthcare, Wessling,
Germany) was washed three times in cell lysis buffer according to
the manufactures instructions (12,000 g for 20 seconds). Fifty percent
slurry of beads and cell lysis buffer was made. Preclearing of the
beads was made by adding 100 ml Protein G Sepharose 4 Fast Flow
to 1 ml cell lysate and gently mixing for 1 hour at 41C. The mixture
was centrifuged at 12,000 g for 20 seconds. The supernatant was
saved for further analysis. Precleared cell lysate (500 mg) and 5mg
anti-MSK2 antibodies (Upstate, Lake Placid, NY) were gently mixed
overnight at 41C. The next day, 50 ml 50% slurry Protein G Sepharose
4 Fast Flow was added and the lysate was mixed gently 2 hours at
41C, before centrifugation at 12,000 g for 20 seconds. The pellet was
washed four times with 1 ml cell lysis buffer, resuspended in 20 ml
1 SDS buffer, and heated to 951C for 3 minutes, before centrifuga-
tion at 12,000 g for 20 seconds. The supernatant was analyzed by
SDS-PAGE as described in Western blot analysis section.
Immunofluorescence
Immunofluorescence of phospho-CREB (Ser133) and total MSK2
were carried out as described previously (Funding et al., 2006).
Tissue sections were immunostained with the anti-phospho-CREB
(Ser133) (Cell Signalling Technology no. 9595) or anti-MSK2 (R&D
Systems) overnight at 41C. The double staining of phospho-MSK2
and -MSK1 was carried out as the single staining, but using the
zenon technology according to manufactures instructions (Molecu-
lar Probes, Eugene, OR). Briefly, nonspecific binding sites were
blocked by 1 hour of incubation in blocking phosphate-buffered
saline (0.5% non-fat dry milk, 1% fish gelatine, 0.3% Triton X-100,
5% goat serum). The tissue sections were incubated overnight with
anti-phospho-MSK2 (Ser196) (R&D Systems). The next day, the
sections were incubated with the secondary antibody (Alexa Flour
594; Molecular Probes) diluted in blocking phosphate-buffered
saline buffer for 2 hours. The sections were blocked with rabbit
serum (2%) before incubation with the zenon-labelled anti-phospho-
MSK1 (Thr581) (Cell Signalling Technology no. 9595b) for 2 hours.
Finally, the sections were fixed in 4% formaldehyde solution in
phosphate-buffered saline for 15 minutes before the nuclear staining
was performed by mounting samples in prolong gold anti-fade
reagent with 40,6-diamidine-20-phenylindole dihydrochloride (Mo-
lecular Probes). To ensure that the staining was not due to
nonspecific binding of the secondary antibody or due to nonspecific
binding of rabbit IgG, negative controls were made incubating the
slides with either blocking buffer, with normal rabbit IgG (phospho-
CREB, -MSK1, -MSK2), normal rat IgG (total-MSK2), or without
primary antibody.
siRNA transfection
Primary keratinocytes were grown to a cell density of 50–60%.
Before the transfection took place, the media were changed to
keratinocyte basal medium. MSK1 siRNA (Pool number M-004665-
01) or MSK2 siRNA (Pool number M-00464-00) and Dharmafect
2 (DHARMACON, Lafayette, CO) were preincubated with
keratinocyte basal medium. The medium-diluted siRNA and the
medium-diluted Dharmafect 2 were incubated for 20 minutes in
order to make complex formation. The siRNA:Dharmafect 2
complexes were added to the cells (final MSK1 and MSK2 siRNA
concentration: 10 nM, MSK1 and MSK2 double siRNA transfection:
20 nM). As control, siControl nontargeting siRNA Pool (10 or 20 nM)
(DHARMACON) was used. Five hours after transfection, the medium
was changed to keratinocyte serum-free medium. The cells were
grown at 371C and 5% CO.
Statistics
Results were expressed as mean7SD. Statistical significance
(Po0.05) was assessed by Student’s t-test.
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